Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

With FDA’s Approval of the Second Biosimilar, Humira to Fight for the Glory of King!

en-cphi.cnSeptember 01, 2017

Tag: Boehringer Ingelheim , AbbVie , HUMIRA (adalimumab) , FDA-approved biosimilar , tumor necrosis factor (TNF)

PharmaSources Customer Service